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Abstract 
The effect of Canavalia ensiformis (DC) seeds on diabetic albino rats was studied.  Alloxan-
induced diabetes mellitus was accompanied by several fold increases in plasma glucose and 
urinary excretion of glucose. Total plasma triacylglycerol, cholesterol and hydroxybutyrate 
were also significantly increased (p<0.05). One-week oral administration of an aqueous extract 
of the seeds of C. ensiformis significantly reduced (p<0.05) hyperlipidaemia and 
hyperketonaemia in the diabetic rats. These results suggest that C. ensiformis seeds possess an 
antidiabetic principle and can be useful for the treatment of diabetes mellitus. 
 















Dietary legumes have been reported to 
influence glycaemia and lipidaemia in man 
and experimental animals. (Malinow et al., 
1980; Bingwen et al., 1981; Molgaard et al., 
1987; Donatucci et al., 1987).  Canavalia 
ensiformis DC (family: Leguminosae) 
variously known as Jack bean, cat eye, horse 
bean, one eye bean and overlook, though a 
native of Central America and West Indies 
has been widely cultivated in the humid 
tropics of Africa and Asia. The seeds have 
been reported to possesss anti- 
hypercholesterolaemic (Marfo et al., 1990) 
and hypoglycaemic (Enyikwola et al., 1991) 
activities. 
 
Diabetes mellitus is a syndrome 
characterized by chronic hyperglycaemia 
and disturbances of carbohydrate, fat and 
protein metabolism associated with absolute 
or relative deficiencies in insulin secretion 
and/or insulin action (Bennett, 1994).  The 
disease is estimated to affect 4-5% of the 
population (Evans, 1999) and patients are 
generally classified as either type 1 (insulin-
dependent) or type 2 (non-insulin 
dependent) diabetics.  For both types of 
diabetes, control of blood glucose levels, 
lipid levels, blood pressure and weight will 
reduce the risk of vascular problems and 
associated diseases (Williams, 1994).   
Earlier work on the effect of C. ensiformis 
on normal and alloxan-induced diabetic rats 
showed statistically significant decreases in 
blood and urinary glucose levels.  In 
addition, there was a lower rate of body 
weight loss in the treated diabetic animals 
(Nimenibo- Uadia and Osagie, 1999).  This 
study reports the effect of C. ensiformis on 
blood total triacylglycerol, cholesterol and 
β-hydroxybutyrate in alloxan-induced 
diabetic rats. 
 




Twenty-four Wistar strain albino rats 
weighing between 180-250g were housed at 
25 + 20C in separate cages (Griffin and 
George Modular Cage System, Model YSM 
580 cage base and YSM 600-540 cage top).  
They were divided into three groups of 8 
animals each and fed ad libitum with 
standard laboratory pellet diet (Pfizer Feeds 




Fifty grams of the pulverized seeds of C. 
ensiformis was boiled in 1 litre of distilled 
water.  After 10 min, the suspension was 
filtered and the filtrate evaporated to dryness 
on a rotary evaporator (Gallenkamp, 
Germany) at 40 oC.  The resulting material 
was stored overnight at −40C and when 
needed, a 5% portion was reconstituted in 
water and used as stock crude drug. 
 
Induction of Diabetes 
 
Diabetes was induced in rats within 72 h by 
the intraperitoneal administration of alloxan 
monohydrate (Sigma, St. Louis, MO, USA) 
dissolved in distilled water (5%) in a dose of 
100mg/kg body weight (Bailey, 1947; 
Nimenibo-Uadia and Osagie, 1999).  They 
were then rested for 3 days to allow glucose 
levels stabilize.  Diabetes was confirmed in 
induced rats by testing for glucosuria using 
glucose indicator sticks (Bayer Diagnostics, 
Basingstoke, UK). Fasting glucose levels in 
blood and a 24h urine sample collected from 
each rat were determined by the glucose 
oxidase-peroxidase enzymatic method 
(Sigma Diagnostics, St. Louis, MO, USA).  
Only rats with fasting blood glucose 
>10mmol/L were considered diabetic and  
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used for further experimentation (Al-Awadi 
et al., 1991). The diabetic animals were then 
divided into diabetic control (Group 2) and 
test rats (Group 3). Animals in Group 1 were 
untreated rats and served as normal control 
receiving distilled water only. 
Pharmacological Evaluation.  
Treatment of test animals with the stock 
crude drug began on day 5 (post-alloxan). 
Using a gavage, group 3 rats were orally 
administered 400 mg/kg body weight of the 
extract, once daily for seven consecutive 
days. The diabetic control rats (group 2) and 
untreated rats (group 1) received distilled 
water by the same route. Fasting blood 
samples for analyses were collected from the 
tail tips of conscious rats every other day 
after an overnight fast (16h) into ice-cold 
sodium fluoride treated plastic tubes and 
centrifuged (MSE minor bench centrifuge).  
Urinary and plasma glucose levels were 
assayed using a glucose oxidase kit 
(Procedure No. 510), purchased from Sigma 
Diagnostics, St. Louis, MO, USA. Sigma 
kits were also employed for the 
colourimetric estimation of total 
triacylglycerol, cholesterol and β-
hydroxybutyrate concentrations in plasma 
(Procedure Nos. 337, 352 and 310-UV 
respectively). The intensity of colour 
produced was measured using a Pye Unicam 




Data were expressed as mean + SEM.  
Differences between the test and control 
groups of animals were evaluated using 
student's t-test (Woodson, 1987).  P<0.05 




Diabetes mellitus in induced rats was 
confirmed by fasting blood glucose levels 
exceeding 10mmol/L (Al-Awadi et al., 
1991).  The diabetic rats presented with 
several fold increases in urine and plasma 
glucose levels. These values were 
significantly higher (p<0.05) than those 
obtained for normal untreated rats (Table 1).  
 
Table 1: Urine and plasma glucose concentrations in 
normal and alloxan-induced diabetic rats before 
treatment with extract (Day 5) 
Group                 Urine 




Normal               0.00 
                           (n=5) 
 
 
Diabetic          14.63±0.37* 







* As compared with normal rats, p<0.05.    Values 
are mean ± S.E.M.  Numbers of animals studied are 
in parenthesis. 
 
Administration of distilled water to control 
animals did not produce any significant 
change (p>0.05) on the urinary and plasma 
glucose, total plasma triacylglycerol, 
cholesterol and β-hydroxybutyrate levels of 
either normal or diabetic rats. However, 
alloxan-induced diabetes mellitus in the rats 
resulted (Tables 2, 3 & 4) in a spectrum of 
severity of hypertriacylglycerolaemia (1.29 
+ 0.02 − 1.85 + 0.01 mmol/L), 
hypercholesterolaemia (2.37 + 0.04 − 3.05 + 
0.04 mmol/L) and hyperketonaemia (1.61 + 
0.18 − 2.69 + 0.15 mmol/L).  
Hyperglycaemic values ranged from 11.10 + 
0.18 − 17.16 + 0.19 mmol/L (laboratory 
note). 
 
The responses of the diabetic rats to the 
administration of C. ensiformis extract are 
shown in Tables 2, 3 & 4. After one week, 
fasting triacylglycerol values declined from  
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Table 2: Effect of C. ensiformis extract on total plasma triacylglycerol concentration in alloxan-induced diabetic 
rats. (Means ± S.E.M.; number of animals in parenthesis)  
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0.05 
(7) 
    *As compared with normal rats within each group, (Day 0) p<0.05.   **As compared with diabetic rats    






















Table 3: Effect of C. ensiformis extract on total plasma cholesterol concentration in alloxan-induced diabetic rats. 
(Means ± S.E.M.; number of animals in parenthesis) 












































































































*As compared with normal rats within each group, (Day 0) p<0.05. **As compared with diabetic rats pre-













        Table 4: Effect of C. ensiformis extract on β-hydroxybutyrate concentration  in alloxan-induced diabetic rats.  
         (Means ± S.E.M.; number of animals in parenthesis)  
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0.08 
(7) 
*As compared with normal rats within each group, (Day 0) p<0.05. **As compared with diabetic rats 









1.83 + 0.01 to 0.76 + 0.05 mmol/L (a 58.5% 
reduction), cholesterol levels were reduced 
from 2.98 + 0.05 to 1.80 + 0.03 mmol/L (a 
39.6% reduction) while β-hydroxybutyrate 
levels fell from 2.37 + 0.17 to 0.50 + 0.08 
mmol/L (a 78.9% reduction). 
DISCUSSION  
 
The statistically significant lowering of 
plasma concentrations of triacylglycerol, 
cholesterol and β-hydroxybutyrate in 
alloxan-induced diabetic rats by oral 
administration of the aqueous extract of the 
seeds of C. ensiformis indicates that the 
extract exhibits antihyperlipidaemic and 
antihyperketonaemic properties. 
 
In alloxan-induced diabetes, the β-cells of 
the islets of Langerhans, which produce 
insulin, are destroyed (Chakravarthy et al., 
1982).  Hyperglycaemia occurs because the 
insulin dependent tissues are unable to take 
up and utilize plasma glucose and also 
because of the enhanced hepatic 
gluconeogenesis from amino acids derived 
from muscle proteins (Rang et al., 1995; 
Granner, 1996).  In severe insulin 
deficiency, there is accelerated lipolysis, 
which results in elevated plasma 
triacylglycerol levels (hyperlipidaemia), as 
observed in the untreated diabetic rats 
(Table 2).  The hypercholesterolaemia 
observed in the untreated diabetic rats 
(Table 3), is due to the high concentration of 
acetyl-CoA obtained from the increased β-
oxidation of fatty acids, acetyl-CoA being a 
key substrate in the biosynthesis of 
cholesterol (Granner, 1996).  Ketosis occurs 
in the absence of insulin because there is 
increased fat breakdown to acetyl-CoA.  In 
the absence of carbohydrate metabolism, 
acetyl-CoA is converted to aceto-acetate, β-
hydroxybutyrate and acetone (Rang et al., 
1995), hence the elevated plasma 
concentration of β-hydroxybutyrate seen in 
the untreated diabetic rats (Table 4).  The 
observations in this study are consistent with 
previous reports that spontaneous diabetes in 
man as well as the experimentally induced 
condition in animals is characterized by 
elevations in the concentrations of the above 
biochemical parameters (West et al., 1966; 
Smith et al., 1983). 
 
Saponin among other secondary metabolites 
has been found present in the aqueous 
extract of C. ensiformis (Nimenibo-Uadia 
and Osagie, 1999).  This may be responsible 
for the lowering effect of this extract on 
blood lipids.  Saponin is known to possess 
blood cholesterol lowering activity.  
Saponins may lower cholesterol by binding 
with cholesterol in the intestinal lumen, 
preventing its absorption, and/or by binding 
with bile acids, causing a reduction in the 
enterohepatic circulation of bile acids and an 
increase in its faecal excretion (Sidhu and 
Oakenful, 1986).  Increased bile acid 
excretion is offset by enhanced bile acid 
synthesis from cholesterol in the liver and 
consequent lowering of the plasma 
cholesterol (Oakenful and Sidhu, 1990). 
 
This study has shown that, oral 
administration of the aqueous extract of C. 
ensiformis seeds can significantly reduce not 
only urinary and blood glucose levels, but 
also elevated levels of triacylglycerol, 
cholesterol and ketone bodies associated 
with diabetes mellitus.  These properties 
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